• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰十二指肠切除术治疗胰导管腺癌后的延长重症监护需求。

The need for extended intensive care after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

机构信息

Department of General, Visceral and Transplant Surgery, University of Heidelberg, Im Neuenheimer Feld 110, Heidelberg, Germany.

出版信息

Langenbecks Arch Surg. 2011 Mar;396(3):353-62. doi: 10.1007/s00423-010-0629-y. Epub 2010 Mar 25.

DOI:10.1007/s00423-010-0629-y
PMID:20336311
Abstract

PURPOSE

Pancreaticoduodenectomy (PD) is standard for patients with resectable pancreatic ductal adenocarcinoma (PDAC) in the pancreatic head, neck, and uncinate process, but it is associated with a relatively high morbidity. This study aimed to identify risk factors for extended postoperative intensive care unit (ICU) admission and assess the impact of ICU treatment on patient survival.

METHODS

Between October 2001 and June 2008, patients that underwent PD for PDAC in the pancreatic head were identified from a prospective database. Patients admitted to the ICU after an initial recovery period were compared to those not admitted regarding comorbidities, intraoperative parameters, resection size, and tumor biology.

RESULTS

Five hundred and forty patients were included. Of these, 17.8% required extended postoperative ICU admission (immediate, 9.3%; delayed, 7.6%). Immediate ICU admission was most frequently required for increased intraoperative blood loss and fluid management. Delayed ICU treatment was most frequently required for hemorrhage, respiratory insufficiency, or pancreatic fistula. Morbidity and 30-day mortality rates were 54.2% and 2.6%, respectively. ICU admission correlated with significantly lower survival rates compared to no ICU admission (P = 0.0155). Multivariate risk factors for ICU admission included a history of diabetes mellitus and heart failure (NYHA I-III), an intraoperative blood transfusion, and a longer operating time.

CONCLUSIONS

The need for extended ICU admission is associated with higher in-hospital mortality and reduced long-term outcome. The highest mortality was observed after delayed ICU admission. Preoperative diabetes, heart failure and long operations, and intraoperative blood transfusions substantially increased the risk for ICU requirement.

摘要

目的

胰十二指肠切除术(PD)是治疗胰头、颈部和钩突部可切除胰腺导管腺癌(PDAC)的标准方法,但它与相对较高的发病率相关。本研究旨在确定延长术后重症监护病房(ICU)入住的风险因素,并评估 ICU 治疗对患者生存的影响。

方法

2001 年 10 月至 2008 年 6 月期间,从一个前瞻性数据库中确定了因 PDAC 在胰头部接受 PD 的患者。将初始恢复期后入住 ICU 的患者与未入住 ICU 的患者进行比较,比较内容包括合并症、术中参数、切除大小和肿瘤生物学。

结果

共纳入 540 例患者。其中,17.8%需要延长术后 ICU 入住(即刻入住,9.3%;延迟入住,7.6%)。即刻入住 ICU 最常因术中出血量增加和液体管理而需要。延迟入住 ICU 最常因出血、呼吸功能不全或胰瘘而需要。发病率和 30 天死亡率分别为 54.2%和 2.6%。与未入住 ICU 相比,入住 ICU 与生存率显著降低相关(P=0.0155)。入住 ICU 的多变量危险因素包括糖尿病和心力衰竭(NYHA I-III)病史、术中输血和手术时间延长。

结论

需要延长 ICU 入住与更高的院内死亡率和降低的长期预后相关。延迟入住 ICU 后的死亡率最高。术前糖尿病、心力衰竭和手术时间长以及术中输血大大增加了入住 ICU 的风险。

相似文献

1
The need for extended intensive care after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.胰十二指肠切除术治疗胰导管腺癌后的延长重症监护需求。
Langenbecks Arch Surg. 2011 Mar;396(3):353-62. doi: 10.1007/s00423-010-0629-y. Epub 2010 Mar 25.
2
Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy.腹腔镜与开腹胰腺切除术治疗导管腺癌:胰体尾切除术和胰十二指肠切除术的独立倾向评分匹配分析。
BMC Cancer. 2021 Apr 9;21(1):382. doi: 10.1186/s12885-021-08117-8.
3
Venous thrombosis following pancreaticoduodenectomy with venous resection.胰十二指肠切除术联合静脉切除术后的静脉血栓形成
J Surg Res. 2018 Aug;228:271-280. doi: 10.1016/j.jss.2018.02.006. Epub 2018 Apr 13.
4
Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma.严重黄疸增加胰腺腺癌胰十二指肠切除术后早期严重并发症发生率并降低长期生存率。
J Am Coll Surg. 2015 Aug;221(2):380-9. doi: 10.1016/j.jamcollsurg.2015.03.058. Epub 2015 Apr 14.
5
Predictors of intensive care unit admission and related outcome for patients after pancreaticoduodenectomy.胰十二指肠切除术后患者重症监护病房入住情况及相关结局的预测因素
J Gastrointest Surg. 2005 Dec;9(9):1307-12. doi: 10.1016/j.gassur.2005.09.010.
6
The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.胰腺内肿瘤位置对胰腺导管腺癌切除术后生存的预后影响。
BMC Surg. 2015 Nov 28;15:123. doi: 10.1186/s12893-015-0110-5.
7
Risk and Predictors of Postoperative Morbidity and Mortality After Pancreaticoduodenectomy for Pancreatic Neuroendocrine Neoplasms: A Comparative Study With Pancreatic Ductal Adenocarcinoma.胰腺神经内分泌肿瘤胰十二指肠切除术后的发病风险及预测因素:与胰腺导管腺癌的比较研究
Pancreas. 2019 Apr;48(4):504-509. doi: 10.1097/MPA.0000000000001273.
8
Portal vein resection in advanced pancreatic adenocarcinoma: is it worth the risk?晚期胰腺腺癌的门静脉切除:冒这个风险值得吗?
Wien Klin Wochenschr. 2016 Aug;128(15-16):566-72. doi: 10.1007/s00508-016-1024-7. Epub 2016 Jun 30.
9
Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas.影响胰头腺癌行门静脉切除术患者预后的因素。
Eur J Surg Oncol. 2012 Jan;38(1):72-9. doi: 10.1016/j.ejso.2011.08.134. Epub 2011 Nov 3.
10
Extended pancreatoduodenectomy as defined by the International Study Group for Pancreatic Surgery is associated with worse survival but not with increased morbidity.国际胰腺手术研究小组所定义的扩大胰十二指肠切除术与较差的生存率相关,但与发病率增加无关。
Surgery. 2015 Jul;158(1):183-90. doi: 10.1016/j.surg.2015.03.015. Epub 2015 Apr 25.

引用本文的文献

1
Pancastatin A and B Have Selective Cytotoxicity on Glucose-Deprived PANC-1 Human Pancreatic Cancer Cells.Pancastatin A 和 B 对葡萄糖剥夺的 PANC-1 人胰腺癌细胞具有选择性细胞毒性。
J Microbiol Biotechnol. 2020 May 28;30(5):733-738. doi: 10.4014/jmb.2002.02002.
2
Perioperative factors impacting intensive care outcomes following Whipple procedure: A retrospective study.胰十二指肠切除术围手术期影响重症监护结局的因素:一项回顾性研究。
Indian J Anaesth. 2020 Mar;64(3):216-221. doi: 10.4103/ija.IJA_727_19. Epub 2020 Mar 11.
3
Pancreatic Cancer: 80 Years of Surgery-Percentage and Repetitions.

本文引用的文献

1
Complications, failure to rescue, and mortality with major inpatient surgery in medicare patients.医疗保险患者重大住院手术的并发症、抢救失败和死亡率。
Ann Surg. 2009 Dec;250(6):1029-34. doi: 10.1097/sla.0b013e3181bef697.
2
Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome.胰腺恶性肿瘤的多脏器切除术:风险分析与长期预后
Ann Surg. 2009 Jul;250(1):81-7. doi: 10.1097/SLA.0b013e3181ad657b.
3
Impact of obesity on perioperative morbidity and mortality after pancreaticoduodenectomy.肥胖对胰十二指肠切除术后围手术期发病率和死亡率的影响。
胰腺癌:80年的手术——百分比与重复情况
HPB Surg. 2016;2016:6839687. doi: 10.1155/2016/6839687. Epub 2016 Oct 25.
4
Survival in solid cancer patients following intensive care unit admission.重症监护病房收治的实体瘤患者的生存情况。
Intensive Care Med. 2014 Oct;40(10):1409-28. doi: 10.1007/s00134-014-3471-9. Epub 2014 Sep 16.
5
Clinical impact of perioperative myocardial infarction after pancreatic surgery.胰腺手术后围手术期心肌梗死的临床影响。
J Gastrointest Surg. 2014 May;18(5):929-34. doi: 10.1007/s11605-014-2453-0. Epub 2014 Jan 15.
6
Prognostic significance of erythropoietin in pancreatic adenocarcinoma.促红细胞生成素在胰腺腺癌中的预后意义。
PLoS One. 2011;6(8):e23151. doi: 10.1371/journal.pone.0023151. Epub 2011 Aug 1.
7
Critical appraisal of the International Study Group of Pancreatic Surgery (ISGPS) consensus definition of postoperative hemorrhage after pancreatoduodenectomy.胰十二指肠切除术后出血的国际胰腺外科研究组 (ISGPS) 共识定义的批判性评价。
Langenbecks Arch Surg. 2011 Aug;396(6):783-91. doi: 10.1007/s00423-011-0811-x. Epub 2011 May 25.
8
Surgical intensive care unit - essential for good outcome in major abdominal surgery?外科重症监护病房——对大型腹部手术的良好预后至关重要?
Langenbecks Arch Surg. 2011 Apr;396(4):417-28. doi: 10.1007/s00423-011-0758-y. Epub 2011 Mar 3.
9
[Diagnosis and definition of anastomotic leakage from the surgeon's perspective].[从外科医生角度看吻合口漏的诊断与定义]
Chirurg. 2011 Jan;82(1):48-55. doi: 10.1007/s00104-010-1916-4.
J Am Coll Surg. 2009 Feb;208(2):210-7. doi: 10.1016/j.jamcollsurg.2008.10.019. Epub 2008 Dec 18.
4
Perioperative glycemic control: an evidence-based review.围手术期血糖控制:一项基于证据的综述。
Anesthesiology. 2009 Feb;110(2):408-21. doi: 10.1097/ALN.0b013e3181948a80.
5
Cancer statistics, 2008.2008年癌症统计数据。
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.
6
POSSUM accurately predicts morbidity for pancreatic resection.POSSUM能够准确预测胰腺切除术的发病率。
Surgery. 2008 Jan;143(1):8-19. doi: 10.1016/j.surg.2007.07.035. Epub 2007 Nov 8.
7
Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution.胰十二指肠切除术后并发症的术前预测因素:体重指数和体脂分布的影响
J Gastrointest Surg. 2008 Feb;12(2):270-8. doi: 10.1007/s11605-007-0421-7. Epub 2007 Dec 1.
8
Hospital volume and late survival after cancer surgery.癌症手术后的医院手术量与远期生存率
Ann Surg. 2007 May;245(5):777-83. doi: 10.1097/01.sla.0000252402.33814.dd.
9
Portal vein resection for advanced pancreatic head cancer.晚期胰头癌的门静脉切除术
J Am Coll Surg. 2007 Apr;204(4):712-6. doi: 10.1016/j.jamcollsurg.2007.01.004. Epub 2007 Feb 26.
10
Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy.胰腺手术后并发症的评估:一种应用于633例行胰十二指肠切除术患者的新型分级系统。
Ann Surg. 2006 Dec;244(6):931-7; discussion 937-9. doi: 10.1097/01.sla.0000246856.03918.9a.